ARN-6039
N/A
Report date: 2023/11/09 15:22:55
NME
Base Information
Drug NameARN-6039
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesArrien Pharmaceuticals Llc
China Registration ClassN/A
Develop Information
Active CompaniesSignalexis IncXenthera IncXenter Inc
Inactive CompaniesBoston Pharmaceuticals IncArrien Pharmaceuticals Llc
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A